An antibody to CD36 reversed the dysfunctional GSIS associated with CD36 overexpression, indicating that CD36 is a candidate therapeutic target for restoring SNARE protein levels and GSIS during obesity-associated T2D [153]. Here, CD36 is linked to obesity disorder.